Past adverse events prompted the US Food and Drug Administration to recommend additional transducer checks in a recent ultrasound guidance document, an agency official said during a recent webinar.
Shahram Vaezy, a biomedical engineer in the FDA’s Center for Devices and Radiological Health (CDRH), discussed “Marketing Clearance of Diagnostic Ultrasound Systems and Transducers” during the Aug. 22 session. The guidance document is notable for dropping 510(k) requirements for many modifications to ultrasound devices
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?